These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9174113

  • 1. Inhibition of influenza virus fusion by polyanionic proteins.
    Schoen P, Corver J, Meijer DK, Wilschut J, Swart PJ.
    Biochem Pharmacol; 1997 Apr 04; 53(7):995-1003. PubMed ID: 9174113
    [Abstract] [Full Text] [Related]

  • 2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW, Schols D, Pauwels R, De Clercq E, Meijer DK.
    Mol Pharmacol; 1993 Nov 04; 44(5):1003-7. PubMed ID: 7902528
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
    Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA.
    Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus.
    Lüscher-Mattli M, Glück R, Kempf C, Zanoni-Grassi M.
    Arch Virol; 1993 Sep 01; 130(3-4):317-26. PubMed ID: 8517791
    [Abstract] [Full Text] [Related]

  • 5. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro.
    Swart PJ, Kuipers ME, Smit C, Pauwels R, deBéthune MP, de Clercq E, Meijer DK, Huisman JG.
    AIDS Res Hum Retroviruses; 1996 Jun 10; 12(9):769-75. PubMed ID: 8738428
    [Abstract] [Full Text] [Related]

  • 6. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
    Cabrera C, Witvrouw M, Gutiérrez A, Clotet B, Kuipers ME, Swart PJ, Meijer DK, Desmyter J, De Clercq E, Esté JA.
    AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1535-43. PubMed ID: 10580404
    [Abstract] [Full Text] [Related]

  • 7. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
    Beljaars L, Floris R, Berkhout B, Smit C, Meijer DK, Molema G.
    Biochem Pharmacol; 2002 May 01; 63(9):1663-73. PubMed ID: 12007569
    [Abstract] [Full Text] [Related]

  • 8. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M, Li ZN, Yao Q, Yang C, Steinhauer DA, Compans RW.
    J Virol; 2006 Jun 01; 80(12):6106-14. PubMed ID: 16731949
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
    Kamps JA, Swart PJ, Morselt HW, Pauwels R, De Béthune MP, De Clercq E, Meijer DK, Scherphof GL.
    Biochim Biophys Acta; 1996 Jan 31; 1278(2):183-90. PubMed ID: 8593275
    [Abstract] [Full Text] [Related]

  • 10. Effect of substitution of hemagglutinin-neuraminidase with influenza hemagglutinin on Sendai virus F protein mediated membrane fusion.
    Bagai S, Sarkar DP.
    FEBS Lett; 1994 Oct 24; 353(3):332-6. PubMed ID: 7957887
    [Abstract] [Full Text] [Related]

  • 11. Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in erythrocytes.
    Pak CC, Blumenthal R.
    Biochim Biophys Acta; 1996 Jan 12; 1278(1):98-104. PubMed ID: 8611613
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetic, immunologic and hematologic studies on the anti-HIV-1/2 compounds aconitylated and succinylated HSA.
    Swart PJ, Beljaars E, Smit C, Pasma A, Schuitemaker H, Meijer DK.
    J Drug Target; 1996 Jan 12; 4(2):109-16. PubMed ID: 8894971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine.
    Günther-Ausborn S, Praetor A, Stegmann T.
    J Biol Chem; 1995 Dec 08; 270(49):29279-85. PubMed ID: 7493959
    [Abstract] [Full Text] [Related]

  • 17. The influence of dextran sulfate on influenza A virus fusion with erythrocyte membranes.
    Herrmann A, Korte T, Arnold K, Hillebrecht B.
    Antiviral Res; 1992 Oct 01; 19(4):295-311. PubMed ID: 1463322
    [Abstract] [Full Text] [Related]

  • 18. Membrane fusion activity of Semliki Forest virus in a liposomal model system: specific inhibition by Zn2+ ions.
    Corver J, Bron R, Snippe H, Kraaijeveld C, Wilschut J.
    Virology; 1997 Nov 10; 238(1):14-21. PubMed ID: 9375004
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones.
    Bodian DL, Yamasaki RB, Buswell RL, Stearns JF, White JM, Kuntz ID.
    Biochemistry; 1993 Mar 30; 32(12):2967-78. PubMed ID: 8457561
    [Abstract] [Full Text] [Related]

  • 20. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
    Schoch C, Blumenthal R.
    J Biol Chem; 1993 May 05; 268(13):9267-74. PubMed ID: 8387488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.